Deal history
5 participations| Date | Company | Round | Raised | Post-money | Role |
|---|---|---|---|---|---|
| Jan 2026 | Neurophos | Later Stage VC (Series A) | ▮ | ▮ | ▮ |
| Jul 2025 | Armada (Commercial Products) | Early Stage VC (Series B2) | ▮ | ▮ | ▮ |
| Aug 2024 | Armada (Commercial Products) | Early Stage VC (Series B1) | ▮ | ▮ | ▮ |
+ 2 more deals · all 5, priced and dated or a free account shows the top 10 names — no card Membership and data by Private Market View | |||||
Investment activity
M12 joined 2 recorded rounds in the last two years (1 in the last 12 months), up from 1 in the two years before. By year: 1 in 2026, 1 in 2025 and 1 in 2024. Across all 5 recorded rounds, 3 were later-stage and 2 were early-stage. M12 most often invests alongside Founders Fund (3 shared rounds), Baillie Gifford (2 shared rounds) and BlackRock (NYS: BLK) (2 shared rounds). Most recently: Neurophos (Series A, Jan 2026) and Armada (Commercial Products) (Series B2, Jul 2025).
Free account
See more of the book
- ·The top 10 names in the book — of 71 recorded positions
- ·The 10 latest deals — of 5 rounds
- ·Watchlist + alerts for M12's activity